Dong-A Socio Holdings Past Earnings Performance
Past criteria checks 5/6
Dong-A Socio Holdings has been growing earnings at an average annual rate of 41.9%, while the Pharmaceuticals industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 9.7% per year. Dong-A Socio Holdings's return on equity is 5.4%, and it has net margins of 5.1%.
Key information
41.9%
Earnings growth rate
41.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 11.3% |
| Revenue growth rate | 9.7% |
| Return on equity | 5.4% |
| Net Margin | 5.1% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Key Things To Watch Out For If You Are After Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) 0.8% Dividend
Apr 29
These 4 Measures Indicate That Dong-A Socio Holdings (KRX:000640) Is Using Debt Extensively
Apr 08Are Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Mixed Financials Driving The Negative Sentiment?
Mar 18What Type Of Shareholders Own The Most Number of Dong-A Socio Holdings Co., Ltd. (KRX:000640) Shares?
Feb 25A Look At Dong-A Socio Holdings' (KRX:000640) Share Price Returns
Feb 04
Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?
Jan 14Is It Smart To Buy Dong-A Socio Holdings Co., Ltd. (KRX:000640) Before It Goes Ex-Dividend?
Dec 24Dong-A Socio Holdings (KRX:000640) Takes On Some Risk With Its Use Of Debt
Dec 13Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Nov 22Revenue & Expenses BreakdownBeta
How Dong-A Socio Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,132,003 | 57,990 | 274,574 | 7,391 |
| 30 Sep 23 | 1,090,776 | 35,900 | 258,060 | 7,208 |
| 30 Jun 23 | 1,070,988 | 37,830 | 241,841 | 6,780 |
| 31 Mar 23 | 1,047,143 | 25,287 | 232,656 | 6,428 |
| 31 Dec 22 | 1,014,861 | 11,153 | 232,799 | 6,423 |
| 30 Sep 22 | 987,861 | 11,836 | 221,600 | 6,154 |
| 30 Jun 22 | 956,813 | 48,972 | 217,976 | 6,454 |
| 31 Mar 22 | 912,995 | 55,623 | 203,523 | 6,527 |
| 31 Dec 21 | 881,944 | 60,271 | 196,199 | 6,518 |
| 30 Sep 21 | 842,393 | 214,113 | 192,783 | 8,139 |
| 30 Jun 21 | 811,312 | 164,235 | 190,050 | 11,992 |
| 31 Mar 21 | 794,394 | 154,770 | 184,254 | 15,336 |
| 31 Dec 20 | 783,316 | 162,345 | 176,947 | 18,847 |
| 30 Sep 20 | 773,052 | 24,709 | 176,166 | 20,303 |
| 30 Jun 20 | 791,145 | 29,376 | 171,572 | 21,667 |
| 31 Mar 20 | 784,283 | 28,740 | 177,057 | 21,681 |
| 31 Dec 19 | 769,686 | 19,764 | 174,466 | 21,462 |
| 30 Sep 19 | 761,452 | -164,895 | 169,017 | 22,683 |
| 30 Jun 19 | 718,971 | -179,438 | 163,863 | 21,552 |
| 31 Mar 19 | 713,877 | -162,620 | 152,432 | 20,812 |
| 31 Dec 18 | 707,496 | -163,977 | 153,574 | 22,178 |
| 30 Sep 18 | 693,713 | 19,654 | 155,478 | 21,652 |
| 30 Jun 18 | 704,635 | 31,054 | 160,668 | 20,430 |
| 31 Mar 18 | 699,011 | 31,706 | 162,696 | 19,834 |
| 31 Dec 17 | 690,265 | 32,543 | 165,653 | 17,590 |
| 30 Sep 17 | 682,172 | 50,055 | 176,900 | 19,289 |
| 30 Jun 17 | 657,706 | 48,323 | 173,801 | 19,564 |
| 31 Mar 17 | 710,128 | 139,838 | 175,949 | 24,569 |
| 31 Dec 16 | 726,166 | 149,051 | 169,826 | 28,672 |
| 30 Sep 16 | 754,540 | 133,406 | 171,708 | 32,137 |
| 30 Jun 16 | 785,651 | 119,810 | 166,610 | 36,109 |
| 31 Mar 16 | 730,411 | 56,947 | 159,144 | 36,272 |
| 31 Dec 15 | 704,735 | 47,883 | 155,997 | 37,217 |
| 30 Sep 15 | 700,837 | 47,127 | 129,542 | 40,171 |
| 30 Jun 15 | 656,037 | 49,820 | 132,264 | 36,265 |
| 31 Mar 15 | 630,003 | 1,212 | 131,039 | 36,327 |
| 31 Dec 14 | 630,625 | 1,716 | 128,355 | 34,912 |
| 30 Sep 14 | 617,966 | 1,945 | 124,921 | 31,242 |
| 30 Jun 14 | 604,687 | 11,975 | 113,734 | 33,456 |
| 31 Mar 14 | 604,029 | 15,124 | 111,762 | 32,626 |
| 31 Dec 13 | 570,870 | 5,201 | 109,077 | 35,351 |
| 30 Sep 13 | 523,923 | 6,308 | 106,336 | 35,275 |
| 30 Jun 13 | 507,918 | 1,333 | 104,305 | 37,583 |
Quality Earnings: A000640 has high quality earnings.
Growing Profit Margin: A000640's current net profit margins (5.1%) are higher than last year (1.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A000640 has become profitable over the past 5 years, growing earnings by 41.9% per year.
Accelerating Growth: A000640's earnings growth over the past year (420%) exceeds its 5-year average (41.9% per year).
Earnings vs Industry: A000640 earnings growth over the past year (420%) exceeded the Pharmaceuticals industry 36.1%.
Return on Equity
High ROE: A000640's Return on Equity (5.4%) is considered low.